Save the date: Glioblastoma Awareness Day — July 22, 2020
Each year, more than 13,000 people are diagnosed with glioblastoma (GBM), the most common, complex, treatment-resistant, and deadliest type of brain cancer. Accounting for 47% of all primary malignant brain tumors, GBM can affect anyone, at any age, including children. Join us on July 22 as we come together to Honor & Act in support of the patients, families, and caregivers who have faced GBM — and raise the national consciousness about ALL Americans stake in finding a cure.
GBM is a monster of a disease. It takes so much from those that are affected — patients, families, caregivers, and loved ones. In the face of a glioblastoma diagnosis, families rely on love, hope, and the promise that research is advancing toward a cure. Every patient and family is different, each with their own journey, but all deserve recognition and action to defeat GBM. On the first annual Glioblastoma Awareness Day in the United States, we ask you to take one day to honor these patients, those we’ve lost, and their families.
Glioblastoma affects men, women, and children — people of any age, background, and walk of life. It does not discriminate on gender, socioeconomic status, region, age, or political party. On GBM Awareness Day, we invite you to learn more about this disease, and how NBTS is leading the charge to bring new treatments to patients faster